| Name | Title | Contact Details |
|---|
Save time, money and resources with the smarter, simpler, and safer way to handle regulated medical waste
Comprehensive Solution for Revenue Generating Medical Ancillary Services
Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA. Arrakis is building a proprietary pipeline of RNA-targeted small molecule (rSM) medicines focused on cancer and genetically validated targets in other disease areas. The company brings together scientific leaders in RNA structure, chemistry and biology, along with a highly experienced management team and the backing of leading life sciences investors. The company is located in Waltham, Massachusetts.
Esperance Pharmaceuticals, Inc. is developing a new class of targeted oncology products that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cancer cell surface. The novel product candidates destroy dividing and non-dividing cancer cells including those known to be resistant to chemotherapeutics.
Sisu Stamina is a company that offers energy chews designed to enhance physical and cognitive performance. Their products are made with potent, clean ingredients to fuel the builders of tomorrow.